SCHEMBL3239181

SCHEMBL3239181

N[C]CCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2852883 0.77
SCHEMBL3401234 0.69 ALDH1A1 (0.35)
SCHEMBL4048169 0.67
SCHEMBL21443128 0.65
SCHEMBL4778593 0.64
SCHEMBL302078 0.64 SELP (0.35)
SCHEMBL201580 0.64
SCHEMBL965817 0.64
SCHEMBL4521757 0.64
1,4-Butanediol SCHEMBL18642509 0.61 SMN1; SMN2 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399489-B2 Antibacterial piperdine derivatives ASTRAZENECA AB (GB) 2013-03-19 US disclosed
US-20100179150-A1 ANTIBACTERIAL PIPERDINE DERIVATIVES ASTRAZENECA AB (SE) 2010-07-15 US disclosed
EP-0691129-A2 Thiazolidone and pyrrolidinone compounds for inhibiting bone loss ELI LILLY AND COMPANY (US) 1996-01-10 EP disclosed
US-5476865-A Administering rhodanine derivatives ELI LILLY AND COMPANY (US) 1995-12-19 US disclosed
US-5356887-A Bone resorption, osteoporosis MERCK & CO., INC. (US) 1994-10-18 US disclosed